T-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Clinical trials for T-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA trials appear
Sign up with your email to follow new studies for T-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a cancer drug boost stem cell transplants for rare T-Cell cancers?
Disease control CompletedThis early-phase study tested adding the drug romidepsin to standard chemotherapy before and after a stem cell transplant in 23 people with certain T-cell cancers. The goal was to find a safe dose and see if the combination could help control the cancer. Participants received the…
Matched conditions: T-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
New drug combo shows promise in preventing relapse after transplant for rare blood cancers
Disease control CompletedThis study tested a low-dose drug called chidamide given after a stem cell transplant to help prevent T-cell acute lymphoblastic leukemia or T-cell lymphoma from coming back. It involved 44 patients aged 14 to 70 who were at high risk of relapse. The main goal was to see how long…
Matched conditions: T-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated May 22, 2026 14:02 UTC